NO20013529L - Modulering av immunrespons med ribavirin - Google Patents

Modulering av immunrespons med ribavirin

Info

Publication number
NO20013529L
NO20013529L NO20013529A NO20013529A NO20013529L NO 20013529 L NO20013529 L NO 20013529L NO 20013529 A NO20013529 A NO 20013529A NO 20013529 A NO20013529 A NO 20013529A NO 20013529 L NO20013529 L NO 20013529L
Authority
NO
Norway
Prior art keywords
ribavirin
modulation
immune response
immune
response
Prior art date
Application number
NO20013529A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013529D0 (no
Inventor
Robert Tam
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of NO20013529D0 publication Critical patent/NO20013529D0/no
Publication of NO20013529L publication Critical patent/NO20013529L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20013529A 1999-01-29 2001-07-17 Modulering av immunrespons med ribavirin NO20013529L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24136799A 1999-01-29 1999-01-29
PCT/US1999/030490 WO2000044388A1 (fr) 1999-01-29 1999-12-20 Modulation de reponse immunitaire par la ribavirine

Publications (2)

Publication Number Publication Date
NO20013529D0 NO20013529D0 (no) 2001-07-17
NO20013529L true NO20013529L (no) 2001-09-12

Family

ID=22910442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013529A NO20013529L (no) 1999-01-29 2001-07-17 Modulering av immunrespons med ribavirin

Country Status (20)

Country Link
EP (1) EP1146883A4 (fr)
JP (1) JP2002535371A (fr)
KR (1) KR20020023939A (fr)
CN (1) CN1334736A (fr)
AU (1) AU2483300A (fr)
BR (1) BR9917090A (fr)
CA (1) CA2357735A1 (fr)
CZ (1) CZ20012519A3 (fr)
HK (1) HK1040937A1 (fr)
HR (1) HRP20010496A2 (fr)
HU (1) HUP0200027A2 (fr)
IL (1) IL144130A0 (fr)
MX (1) MXPA01007211A (fr)
NO (1) NO20013529L (fr)
PL (1) PL364699A1 (fr)
RU (1) RU2211698C2 (fr)
SI (1) SI20802A (fr)
SK (1) SK10092001A3 (fr)
WO (1) WO2000044388A1 (fr)
ZA (1) ZA200105595B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN101410122A (zh) * 2006-03-14 2009-04-15 厚生药业股份有限公司 治疗过敏性疾病的方法及组合物
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
EP0038629A1 (fr) * 1980-04-17 1981-10-28 Beecham Group Plc Dérivés du virazole, procédé pour leur préparation et leur utilisation comme agents antiviraux
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
AU5668886A (en) * 1986-03-27 1987-10-20 Harry Edward Gruber A method of increasing adenosine excretion
US5030623A (en) * 1986-03-27 1991-07-09 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
RU2088232C1 (ru) * 1995-02-14 1997-08-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Ингибитор репродукции вируса марбург
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
PL187439B1 (pl) * 1996-01-23 2004-07-30 Icn Pharmaceuticals Zastosowanie rybawiryny
ATE238328T1 (de) * 1996-10-16 2003-05-15 Ribapharm Inc Monozyklische l-nukleoside, analoga und ihre anwendungen

Also Published As

Publication number Publication date
SI20802A (sl) 2002-08-31
WO2000044388A1 (fr) 2000-08-03
EP1146883A4 (fr) 2004-11-24
HRP20010496A2 (en) 2003-08-31
CN1334736A (zh) 2002-02-06
MXPA01007211A (es) 2002-05-06
NO20013529D0 (no) 2001-07-17
CA2357735A1 (fr) 2000-08-03
JP2002535371A (ja) 2002-10-22
CZ20012519A3 (cs) 2002-05-15
HUP0200027A2 (en) 2002-04-29
BR9917090A (pt) 2001-10-16
IL144130A0 (en) 2002-05-23
EP1146883A1 (fr) 2001-10-24
KR20020023939A (ko) 2002-03-29
HK1040937A1 (zh) 2002-06-28
RU2211698C2 (ru) 2003-09-10
SK10092001A3 (sk) 2002-02-05
AU2483300A (en) 2000-08-18
ZA200105595B (en) 2002-10-07
PL364699A1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
DE60019197D1 (de) System mit Regelung der Geschwindigkeitssynchronisierung von Ventilatoren
DE69840690D1 (de) Selbst-zwischengitterdominiertes Silizium mit niedriger Fehlerdichte
NO20021533L (no) Meget fölsomt akselerometer
ATE423827T1 (de) Multifunktionalschmelzhaftkleber
DE69908417D1 (de) Wärme entklebbare klebstoffzusammensetzung und klebestruktur
ATE266069T1 (de) Sprühbarer schmelzklebstoff
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO994790D0 (no) Estimering av permabilitet
EP1206478A4 (fr) Composes antisens modulant l'expression de mekk5
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20015505D0 (no) Fremstilling av komplekse karbohydrater
NO20013529D0 (no) Modulering av immunrespons med ribavirin
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
ID27835A (id) Piranti elektromagnit dan sirkuit untuk menggerakan piranti elektromagnit
DE60025033D1 (de) Kochplatte
EP1200573A4 (fr) Modulation antisens de l'expression de la proteine kinase 1 activee par mitogene (mekk1)
DE60041878D1 (de) Pcm-modem mit vorkodierung und vorentzerrung
DE60035089D1 (de) Verbindungs- und Trägerelement
NO20021260L (no) Estimering av amplityde-spektra
FI980268A0 (fi) Foerfarande foer framstaellning av cykliska monomerer
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO992607D0 (no) System med sÕrhelende virkning
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
NO20021234L (no) Anvendelse av tienopyrimidiner
FIU990032U0 (fi) Hirsikerautapari

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application